PL4238565T3 - Kompozycja farmaceutyczna do zapobiegania lub leczenia wirusowej choroby okolic pochwy - Google Patents

Kompozycja farmaceutyczna do zapobiegania lub leczenia wirusowej choroby okolic pochwy

Info

Publication number
PL4238565T3
PL4238565T3 PL21885567.4T PL21885567T PL4238565T3 PL 4238565 T3 PL4238565 T3 PL 4238565T3 PL 21885567 T PL21885567 T PL 21885567T PL 4238565 T3 PL4238565 T3 PL 4238565T3
Authority
PL
Poland
Prior art keywords
perivaginal
disease
preventing
pharmaceutical composition
treating viral
Prior art date
Application number
PL21885567.4T
Other languages
English (en)
Inventor
Hiroshi Onogi
Tetsuo Yamaguchi
Katsuhiko Sato
Original Assignee
Kinopharma, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinopharma, Inc. filed Critical Kinopharma, Inc.
Publication of PL4238565T3 publication Critical patent/PL4238565T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL21885567.4T 2020-10-28 2021-02-19 Kompozycja farmaceutyczna do zapobiegania lub leczenia wirusowej choroby okolic pochwy PL4238565T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020180339 2020-10-28
PCT/JP2021/006418 WO2022091442A1 (ja) 2020-10-28 2021-02-19 ウイルス性腟周辺部疾患の予防又は治療のための医薬組成物

Publications (1)

Publication Number Publication Date
PL4238565T3 true PL4238565T3 (pl) 2025-12-22

Family

ID=81382191

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21885567.4T PL4238565T3 (pl) 2020-10-28 2021-02-19 Kompozycja farmaceutyczna do zapobiegania lub leczenia wirusowej choroby okolic pochwy

Country Status (11)

Country Link
US (1) US20230398107A1 (pl)
EP (1) EP4238565B1 (pl)
JP (1) JP7606239B2 (pl)
KR (1) KR20230098175A (pl)
CN (1) CN115734782A (pl)
CA (1) CA3199945A1 (pl)
ES (1) ES3045576T3 (pl)
PL (1) PL4238565T3 (pl)
TW (1) TWI890738B (pl)
WO (1) WO2022091442A1 (pl)
ZA (1) ZA202304812B (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63275519A (ja) * 1987-05-06 1988-11-14 Taisho Pharmaceut Co Ltd 難溶性薬物含有顆粒の製造方法
JP2001081031A (ja) 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
AU2004312083A1 (en) 2003-12-29 2005-07-21 Alza Corporation, Inc. Drug granule coatings that impart smear resistance during mechanical compression
JP5349309B2 (ja) * 2007-08-03 2013-11-20 株式会社キノファーマ 抗dnaウイルス作用を有するアニリン誘導体
JP2010189337A (ja) * 2009-02-19 2010-09-02 Asahi Breweries Ltd 難溶性物質を含有する顆粒、錠剤、及び難溶性物質の可溶化方法
JP6138635B2 (ja) * 2013-08-30 2017-05-31 旭化成株式会社 セルロース系核粒子及びその製造方法
WO2020218517A1 (ja) * 2019-04-25 2020-10-29 富士製薬工業株式会社 医薬製剤およびその製造方法
BR112021021232A2 (pt) * 2019-04-25 2021-12-21 Fuji Pharma Co Ltd Preparação farmacêutica na forma de grânulos, preparação, método de produção de uma preparação farmacêutica e métodos para a produção de comprimidos e para a produção de cápsulas

Also Published As

Publication number Publication date
EP4238565B1 (en) 2025-09-24
ZA202304812B (en) 2024-08-28
JPWO2022091442A1 (pl) 2022-05-05
EP4238565A4 (en) 2024-10-09
KR20230098175A (ko) 2023-07-03
TW202216142A (zh) 2022-05-01
US20230398107A1 (en) 2023-12-14
WO2022091442A1 (ja) 2022-05-05
EP4238565A1 (en) 2023-09-06
CA3199945A1 (en) 2022-05-05
TWI890738B (zh) 2025-07-21
CN115734782A (zh) 2023-03-03
ES3045576T3 (en) 2025-11-28
JP7606239B2 (ja) 2024-12-25
EP4238565C0 (en) 2025-09-24

Similar Documents

Publication Publication Date Title
IL285782A (en) Compounds, compositions, and methods for treating disease
EP3954395A4 (en) Pharmaceutical composition for muscle disease treatment
PL4157272T3 (pl) Remdesiwir do leczenia zakażeń wirusowych
IL290792A (en) Preparations and methods for treating viral infections
ZA200810531B (en) Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown
IL285221A (en) Use of oncolytic viruses to treat cancer
SG11202109512SA (en) Leucine, acetyl leucine, and related analogs for treating disease
ZA202202370B (en) Compositions and methods for treating viral infections
IL289213A (en) A pharmaceutical preparation for tumor treatment
EP4074316A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
IL279078A (en) Combination therapy for the treatment of hepatitis B viral infection
IL273843A (en) Pharmaceutical compositions for the treatment of the corona virus disease covid-19
KR102316727B9 (ko) 아토피성 질환 예방 또는 치료용 약학적 조성물
PL4238565T3 (pl) Kompozycja farmaceutyczna do zapobiegania lub leczenia wirusowej choroby okolic pochwy
GB201908453D0 (en) Compounds for treating respiratory disease
GB201816547D0 (en) Oncolytic virus for the treatment of cancer
IL291476A (en) A pharmacological compound for the treatment of proctological diseases (variants)
IL286680A (en) A drug to treat cancer
SI4021505T1 (sl) Zdravilo za zdravljenje nalezljivih bolezni
HUE067327T2 (hu) Vírusos légúti fertõzések kezelése
EP3936118A4 (en) PHARMACEUTICAL COMPOSITION FOR IMMUNACTIVITY OR PREVENTION OR TREATMENT OF CANCER
KR102276379B9 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물
GB201911728D0 (en) Bacterial composistions for the treatment of disease
KR102090101B9 (ko) 구강 질환 예방 또는 치료용 조성물
SG11202105231UA (en) Pharmaceutical composition for treating wounds